THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted:
No date available
»Therapeutic Categories: Anesthesia; Neurology; Pediatric
Accord Healthcare Inc. (Revised 04/18/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Available | Demand increase for the drug | |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Available | Demand increase for the drug | |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Available | Demand increase for the drug | |
| Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Available | ||
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-45) | Inventory on hold pending further assessment | Inventory on hold pending further assessment | |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Available |
American Regent, Inc. (Revised 09/07/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | Available | old NDC 0517-1010-25 | Demand increase for the drug |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | Available | old NDC 0517-0401-25 | Demand increase for the drug |
Amphastar Pharmaceuticals, Inc. (Revised 09/07/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Available |
Fresenius Kabi USA, LLC (Reverified 09/01/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Available | Check wholesalers for inventory | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Revised 05/18/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0641-6251-10) | Inventory is currently available. | Additional lots are scheduled for manufacturing. Product will be made available as it is released. |
Hospira, Inc. (Revised 09/11/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-1630-10) | Depleted | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Regulatory delay |
| Atropine Sulfate, Injection, .05 mg/1 mL (NDC 0409-9630-05) | Available | Demand increase for the drug | |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-4910-34) | Limited Supply Available. | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-4911-34) | Depleted | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| Injection, 0.1 mg/mL, 10 mL (NDC 0409-4911-11) | Next Delivery: August 2023; Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay |
Medefil, Inc. (New 06/15/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 64253-400-91) | Available | Demand increase for the drug |